CompoAtlas

Joint Solutions

Natural health product licensed in Canada

Licence holder
CCS Global Import Solutions
NPN or DIN-HM
80028521
Status
Active licence
Licence date
7 December 2011
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de glucosamine

Source : Glucosamine sulfate 2KCl de chitine des carapaces de crustacés

300 mgNot calculated
Collagène de type II hydrolysé

Source : Gallus gallus - cartilage

Potency : 40 mg Chondroitin sulfate

200 mgNot calculated
Collagène de type II hydrolysé

Source : Gallus gallus - cartilage

Potency : 20 mg Hyaluronic acid

Not specifiedNot calculated

Non-medicinal ingredients

Cellulose - microcrystalline, Hypromellose, Stéarate de magnésium végétal, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified5 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis, protect against the deterioration of cartilage and a factor in maintaining healthy cartilage and joints.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80028521

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line